ARAV Chart
See on advanced chart >
About
Aravive, Inc.(Nasdaq: ARAV effective October 16, 2018) is a clinical stage biotechnology company focused on developing innovative therapies that target important survival pathways for cancer. Aravive's lead candidate, AVB-S6-500, is a novel, high-affinity,...
Read More
- HighlightA late clinical-stage oncology company that develops targeted therapeutics to treat metastatic disease
- ExchangeNASDAQ
- Listing Date03/21/2014
- Established DateInvalid Date
- Full-time Employees23
- AddressRiver Oaks Tower 3730 Kirby Drive Suite 1200 Houston Texas 77098
- Tel1-936-3551910
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry